Form 4: Lilly Endowment Inc. Sells 2,052 Shares of Eli Lilly & Co.

Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., sold 2,052 shares of common stock at a price of $809 per share on May 28, 2024.

Summary

• Lilly Endowment Inc. sold 2,052 shares of Eli Lilly & Co. common stock on May 28, 2024.
• The sale price was $809 per share.
• Following the transaction, Lilly Endowment Inc. beneficially owns 98,554,195 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a major shareholder, with no indication of positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, indicating a change in beneficial ownership by a major shareholder. Such filings are common and provide transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders in publicly traded companies.
• The transaction is relatively small compared to the total holdings of Lilly Endowment Inc. in Eli Lilly & Co.

Stakeholder Impact

• The sale of shares by a major shareholder could have a minor impact on the stock price, but the transaction is relatively small.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, stock sale, share transaction, beneficial ownership, LLY